Insulin-like growth factor I and prostate cancer

By O'Brien M.F.   Watson R.W.G.   Fitzpatrick J.M.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer

By Oort I.   Witjes J.   Kok D.   Kiemeney L.   Hulsbergen-vandeKaa C.  

World Journal of Urology, Vol. 26, Iss. 3, 2008-06 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

By Tricoli J.V.   Winter D.L.   Hanlon A.L.   Raysor S.L.   Watkins-Bruner D.   Pinover W.H.   Hanks G.E.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 178-182

Elsevier

Access to resources Recommend Favorite

Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate

By Werner-Wasik M.   Whittington R.   Malkowicz S.B.   Corn B.W.   Arger P.   Reisinger S.   Langlotz C.   Alexander A.   D'Amico A.V.   Hyslop T.   Gomella L.   Brownstein K.   Wein A.J.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 385-389

Elsevier

Access to resources Recommend Favorite